DK0537313T3 - Arylalkylestere af 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre med terapeutisk aktivitet - Google Patents

Arylalkylestere af 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre med terapeutisk aktivitet

Info

Publication number
DK0537313T3
DK0537313T3 DK92909059.5T DK92909059T DK0537313T3 DK 0537313 T3 DK0537313 T3 DK 0537313T3 DK 92909059 T DK92909059 T DK 92909059T DK 0537313 T3 DK0537313 T3 DK 0537313T3
Authority
DK
Denmark
Prior art keywords
dioxo
dihydro
dihydroxy
arylalkyl esters
therapeutic activity
Prior art date
Application number
DK92909059.5T
Other languages
Danish (da)
English (en)
Inventor
Sergio Rosini
Maurizio Mian
Original Assignee
Gentili Ist Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gentili Ist Spa filed Critical Gentili Ist Spa
Application granted granted Critical
Publication of DK0537313T3 publication Critical patent/DK0537313T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/95Esters of quinone carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/24Anthracenes; Hydrogenated anthracenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Steroid Compounds (AREA)
DK92909059.5T 1991-05-03 1992-04-21 Arylalkylestere af 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre med terapeutisk aktivitet DK0537313T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI911215A IT1247884B (it) 1991-05-03 1991-05-03 Esteri arilalchilici dell'acido 4,5 diidrossi-9,10-diidro-9,10-diosso 2-antracencarbossilico ad azione terapeutica

Publications (1)

Publication Number Publication Date
DK0537313T3 true DK0537313T3 (da) 1996-06-03

Family

ID=11359835

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92909059.5T DK0537313T3 (da) 1991-05-03 1992-04-21 Arylalkylestere af 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre med terapeutisk aktivitet

Country Status (21)

Country Link
US (1) US5330981A (cs)
EP (1) EP0537313B1 (cs)
JP (1) JPH0692348B2 (cs)
KR (1) KR100226082B1 (cs)
AT (1) ATE133157T1 (cs)
AU (1) AU648894B2 (cs)
BR (1) BR9205255A (cs)
CZ (1) CZ280027B6 (cs)
DE (1) DE69207698T2 (cs)
DK (1) DK0537313T3 (cs)
ES (1) ES2082468T3 (cs)
FI (1) FI104166B1 (cs)
GR (1) GR3019417T3 (cs)
HU (1) HUT63605A (cs)
IT (1) IT1247884B (cs)
MX (1) MX9202015A (cs)
NO (1) NO179245C (cs)
PT (1) PT100439B (cs)
RU (1) RU2087462C1 (cs)
SK (1) SK280738B6 (cs)
WO (1) WO1992019584A1 (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9417102D0 (en) * 1994-08-24 1994-10-12 Lilly Industries Ltd Pharmaceutical compounds
CA2495537C (en) * 2000-08-29 2010-03-30 Nobex Corporation Immunoregulatory compounds and derivatives and methods of treating diseases therewith
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
US7932366B2 (en) 2004-07-07 2011-04-26 Biocon Limited Synthesis of azo bonded immunoregulatory compounds
CN101475484B (zh) * 2009-01-05 2012-07-18 东南大学 骨靶向抗炎药物合成方法及其应用
CN103709052B (zh) * 2014-01-12 2016-01-27 何黎琴 一种大黄酸胺基醇酯类化合物、其制备方法及医药用途
CN104945269A (zh) * 2015-06-23 2015-09-30 常州善美药物研究开发中心有限公司 一种大黄酸羧酸酯类衍生物及其应用
CN109053798B (zh) * 2018-07-23 2020-11-17 遵义医科大学 一种大黄酸酯衍生物及其制备方法与应用
CN115521320B (zh) * 2021-06-25 2023-09-05 沈阳兴齐眼药股份有限公司 一种制备普拉洛芬的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA761627B (en) * 1976-03-16 1978-01-25 C Friedmann Improvements in or relating to the treatment of arthritis

Also Published As

Publication number Publication date
AU1670092A (en) 1992-12-21
ATE133157T1 (de) 1996-02-15
NO179245B (no) 1996-05-28
CZ280027B6 (cs) 1995-09-13
FI104166B (fi) 1999-11-30
JPH0692348B2 (ja) 1994-11-16
DE69207698D1 (de) 1996-02-29
IT1247884B (it) 1995-01-05
NO179245C (no) 1996-09-04
EP0537313B1 (en) 1996-01-17
SK280738B6 (sk) 2000-07-11
PT100439A (pt) 1993-08-31
HU9204171D0 (en) 1993-04-28
AU648894B2 (en) 1994-05-05
FI925944A0 (fi) 1992-12-30
SK386492A3 (en) 1995-04-12
KR100226082B1 (en) 1999-10-15
GR3019417T3 (en) 1996-06-30
DE69207698T2 (de) 1996-07-18
US5330981A (en) 1994-07-19
PT100439B (pt) 1999-10-29
NO925048L (no) 1992-12-30
MX9202015A (es) 1992-11-01
CZ386492A3 (en) 1993-06-16
FI104166B1 (fi) 1999-11-30
WO1992019584A1 (en) 1992-11-12
JPH05507733A (ja) 1993-11-04
BR9205255A (pt) 1993-08-31
ITMI911215A1 (it) 1992-11-03
ES2082468T3 (es) 1996-03-16
FI925944L (fi) 1992-12-30
HUT63605A (en) 1993-09-28
ITMI911215A0 (it) 1991-05-03
EP0537313A1 (en) 1993-04-21
NO925048D0 (no) 1992-12-30
RU2087462C1 (ru) 1997-08-20

Similar Documents

Publication Publication Date Title
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
DE69217078D1 (de) Unterlage für die behandlung von urininkontinenz
DE69221501D1 (de) Verfahren zum vermindern von durch medizinische vorrichtungen bedingten infektionen
CS29990A3 (en) Racemic or optically active bis-aza-bicyclic compounds, process forpreparing thereof, intermediates and use
FI934342A7 (fi) Menetelmä kollageenin valmistamiseksi: menetelmällä valmistettu kollag eeni ja kollageenin käyttö
DE69600084D1 (de) Verwendung von hydroxylierte Carbonsäure zur Behandlung von Nägeln
DK0424028T3 (da) S(+)-ibuprofen-L-aminosyre og S(+)-ibuprofen-D-aminosyre som et forbedret smertestillende middel med fremskyndet indtrædelse
DE3772247D1 (de) Diacetylrheinsaeure-kaliumsalze und seine verwendung zur behandlung von arthritis.
DK0537313T3 (da) Arylalkylestere af 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre med terapeutisk aktivitet
FR2491334B1 (cs)
SE9300758D0 (sv) Process for the production of clavulanic acid
LV10839A (lv) Arstniecibas lidzeklis lipidu un holesterina vielmainas traucejumu profilaksei un arstesanai so traucejumu profilakses un arstesanas panemiens
DK0561846T3 (da) 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
DK0413329T3 (da) 5-methyl-isoxazol-4-carboxylsyreanilider og 2-hydroxyethyliden-cyaneddikesyreanilider til behandling af øjensygdomme
BR8807555A (pt) Processo de producao de filamento de metal e aparelho para materializacao do dito processo
DE59206872D1 (de) Verwendung von torasemid zur behandlung von hirnödemen
TR27462A (tr) Sübstitüe edilmis sinamik asidi hidroksiamid'leri, bunlarin üretilmesine mahsus usul, bunlari ihtiva eden maddeler ve bunlarin kullanilmasi.
DE69427116D1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
DE69131058D1 (de) Verwendung einer therapeutischen Zusammensetzung zur Behandlung von Bronchitis
BG45853A3 (bg) Метод за получаване на бензамидни съединения
ES2122236T3 (es) Sal de lisina de la 6-cloro-5-fluoro-3-(2-tenoil)-2-oxindol-1-carboxamida.
AT358573B (de) Verfahren zur herstellung von (1,1-dithienyl- -(3-propen-(1)-yl-(3))-(1-phenyl-1-hydroxy- propyl-2))-amin und dessen saeureadditions- salzen und optisch aktiven isomeren
FR2686441B1 (fr) Procede de gestion et d'ordonnancement du travail personnel d'un individu.
IT8019033A0 (it) Metodo per il trattamento disuperfici siero-essudanti dell'epidermide, ferite, piaghe esimili, e mezzi per la sua attuazione.
ATE101054T1 (de) Einrichtung zur diagnostik und behandlung von nasenerkrankungen.